Impedimed (Australia) Market Value
| IPD Stock | 0.05 0 2.00% |
| Symbol | Impedimed |
Impedimed 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Impedimed's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Impedimed.
| 10/31/2024 |
| 11/30/2024 |
If you would invest 0.00 in Impedimed on October 31, 2024 and sell it all today you would earn a total of 0.00 from holding Impedimed or generate 0.0% return on investment in Impedimed over 30 days. Impedimed is related to or competes with Hotel Property, Dexus Convenience, Vulcan Steel, and BKI Investment. Impedimed is entity of Australia. It is traded as Stock on AU exchange. More
Impedimed Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Impedimed's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Impedimed upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.94 | |||
| Information Ratio | 0.0109 | |||
| Maximum Drawdown | 29.12 | |||
| Value At Risk | (4.62) | |||
| Potential Upside | 6.0 |
Impedimed Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Impedimed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Impedimed's standard deviation. In reality, there are many statistical measures that can use Impedimed historical prices to predict the future Impedimed's volatility.| Risk Adjusted Performance | 0.0401 | |||
| Jensen Alpha | 0.1018 | |||
| Total Risk Alpha | (0.57) | |||
| Sortino Ratio | 0.0125 | |||
| Treynor Ratio | 0.301 |
Impedimed Backtested Returns
Currently, Impedimed is out of control. Impedimed holds Efficiency (Sharpe) Ratio of 0.0417, which attests that the entity had a 0.0417% return per unit of risk over the last 3 months. We have found thirty technical indicators for Impedimed, which you can use to evaluate the volatility of the firm. Please check out Impedimed's Market Risk Adjusted Performance of 0.311, downside deviation of 3.94, and Risk Adjusted Performance of 0.0401 to validate if the risk estimate we provide is consistent with the expected return of 0.19%. Impedimed has a performance score of 3 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.59, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Impedimed's returns are expected to increase less than the market. However, during the bear market, the loss of holding Impedimed is expected to be smaller as well. Impedimed right now retains a risk of 4.48%. Please check out Impedimed jensen alpha, sortino ratio, maximum drawdown, as well as the relationship between the total risk alpha and treynor ratio , to decide if Impedimed will be following its current trending patterns.
Auto-correlation | 0.07 |
Virtually no predictability
Impedimed has virtually no predictability. Overlapping area represents the amount of predictability between Impedimed time series from 31st of October 2024 to 15th of November 2024 and 15th of November 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Impedimed price movement. The serial correlation of 0.07 indicates that barely 7.0% of current Impedimed price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.07 | |
| Spearman Rank Test | 0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Impedimed lagged returns against current returns
Autocorrelation, which is Impedimed stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Impedimed's stock expected returns. We can calculate the autocorrelation of Impedimed returns to help us make a trade decision. For example, suppose you find that Impedimed has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Impedimed regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Impedimed stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Impedimed stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Impedimed stock over time.
Current vs Lagged Prices |
| Timeline |
Impedimed Lagged Returns
When evaluating Impedimed's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Impedimed stock have on its future price. Impedimed autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Impedimed autocorrelation shows the relationship between Impedimed stock current value and its past values and can show if there is a momentum factor associated with investing in Impedimed.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Impedimed Stock Analysis
When running Impedimed's price analysis, check to measure Impedimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Impedimed is operating at the current time. Most of Impedimed's value examination focuses on studying past and present price action to predict the probability of Impedimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Impedimed's price. Additionally, you may evaluate how the addition of Impedimed to your portfolios can decrease your overall portfolio volatility.